119 related articles for article (PubMed ID: 9038688)
1. Antithrombotic treatment in stable coronary syndromes: long-term intermittent urokinase therapy in end-stage coronary artery disease and refractory angina pectoris.
Schoebel FC; Jax TW; Fischer Y; Strauer BE; Leschke M
Heart; 1997 Jan; 77(1):13-7. PubMed ID: 9038688
[TBL] [Abstract][Full Text] [Related]
2. Long-term intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris: a randomized dose-response trial.
Leschke M; Schoebel FC; Mecklenbeck W; Stein D; Jax TW; Müller-Gärtner HW; Strauer BE
J Am Coll Cardiol; 1996 Mar; 27(3):575-84. PubMed ID: 8606267
[TBL] [Abstract][Full Text] [Related]
3. Low-dose intermittent urokinase therapy in chronic symptomatic end-stage arterial disease--clinical relevance for patients with coronary artery disease or peripheral arterial occlusive disease.
Leschke M; Schoebel FC; Strauer BE
Clin Hemorheol Microcirc; 1997; 17(1):59-66. PubMed ID: 9181759
[TBL] [Abstract][Full Text] [Related]
4. Chronic-intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris--a pilot study.
Schoebel FC; Leschke M; Jax TW; Stein D; Strauer BE
Clin Cardiol; 1996 Feb; 19(2):115-20. PubMed ID: 8821421
[TBL] [Abstract][Full Text] [Related]
5. [Chronic intermittent urokinase therapy: anti-ischemic and hemodynamic effects].
Leschke M; Schoebel FC; Schannwell CM; Peters AJ; Jax TW; Mecklenbeck W; Strauer BE
Z Kardiol; 1997; 86 Suppl 1():85-94. PubMed ID: 9173724
[TBL] [Abstract][Full Text] [Related]
6. [Conservative therapeutic approaches in terminal coronary heart disease. Chronic intermittent urokinase therapy].
Leschke M; Schoebel FC; Jax TW; Schannwell CM; Marx R; Strauer BE
Herz; 1997 Oct; 22(5):262-71. PubMed ID: 9441157
[TBL] [Abstract][Full Text] [Related]
7. [Chronic intermittent urokinase therapy in therapy-refractory angina pectoris].
Leschke M; Höffken H; Motz W; Blanke H; Schöbel F; Strauer BE
Dtsch Med Wochenschr; 1992 Jan; 117(3):81-7. PubMed ID: 1730212
[TBL] [Abstract][Full Text] [Related]
8. [Assessment of the anti-ischemic effect in patients with therapy refractory angina pectoris in end-stage coronary heart disease--results of chronic intermittent urokinase therapy].
Schoebel FC; Peters AJ; Schannwell CM; Holz B; Jax TW; Leschke M; Strauer BE
Z Kardiol; 1998; 87 Suppl 2():188-92. PubMed ID: 9827480
[TBL] [Abstract][Full Text] [Related]
9. [Chronic intermittent urokinase therapy in inoperable end-stage coronary disease with therapy refractory angina pectoris symptoms].
Leschke M; Mecklenbeck W; Strauer BE
Med Klin (Munich); 1992 Jul; 87(7):385-9. PubMed ID: 1508119
[No Abstract] [Full Text] [Related]
10. Refractory angina pectoris in end-stage coronary artery disease: evolving therapeutic concepts.
Schoebel FC; Frazier OH; Jessurun GA; De Jongste MJ; Kadipasaoglu KA; Jax TW; Heintzen MP; Cooley DA; Strauer BE; Leschke M
Am Heart J; 1997 Oct; 134(4):587-602. PubMed ID: 9351724
[TBL] [Abstract][Full Text] [Related]
11. [Thrombolytic therapy].
Matsuda T
Nihon Rinsho; 1998 Oct; 56(10):2577-81. PubMed ID: 9796322
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy of thrombolytic therapy for acute myocardial infarction in patients with and without chronic preinfarction angina.
Ohno A; Fujita M; Yamanishi K; Miwa K; Nozawa T
Cardiology; 1993; 83(1-2):93-9. PubMed ID: 8261493
[TBL] [Abstract][Full Text] [Related]
13. Thrombolysis in the management of acute myocardial infarction and unstable angina pectoris.
Loscalzo J
Drugs; 1989 Feb; 37(2):191-204. PubMed ID: 2649355
[TBL] [Abstract][Full Text] [Related]
14. Influence of different start time of urokinase therapy after acute myocardial infarction efficacy of thrombolysis. The Collaborative Research Group on Thrombolysis.
Chin Med J (Engl); 1997 Jan; 110(1):47-9. PubMed ID: 9594321
[TBL] [Abstract][Full Text] [Related]
15. Alteplase. A reappraisal of its pharmacology and therapeutic use in vascular disorders other than acute myocardial infarction.
Wagstaff AJ; Gillis JC; Goa KL
Drugs; 1995 Aug; 50(2):289-316. PubMed ID: 8521760
[TBL] [Abstract][Full Text] [Related]
16. Thrombolysis with recombinant human single-chain urokinase-type plasminogen activator (rscu-PA): dose-response in dogs with coronary artery thrombosis.
Van de Werf F; Jang IK; Collen D
J Cardiovasc Pharmacol; 1987 Jan; 9(1):91-3. PubMed ID: 2434801
[TBL] [Abstract][Full Text] [Related]
17. [Therapy and prognosis of intravascular coagulation].
Nobuyoshi M
Nihon Rinsho; 1983; 41(2):385-93. PubMed ID: 6865011
[No Abstract] [Full Text] [Related]
18. Coronary thrombolysis with clot-selective plasminogen activators.
Collen D; Bounameaux H
Herz; 1986 Feb; 11(1):9-15. PubMed ID: 3082731
[TBL] [Abstract][Full Text] [Related]
19. [Rheology and coronary heart disease].
Leschke M
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S270-3. PubMed ID: 19085805
[TBL] [Abstract][Full Text] [Related]
20. [New thrombolytic agents in myocardial infarction].
Charbonnier B; Lang M; Brochier M
Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
